Business development
A key driver of the company's long-term growth and international expansion
Business Development
As CinnaGen, our business development efforts are a key driver of our long-term growth and international expansion. Through these collective capabilities, we strengthen our global presence, enhance our competitive position, and create sustainable value across international markets.
We are committed to building long-term relationships with partners, regulatory bodies, research centers, and healthcare stakeholders worldwide. These collaborations reinforce our mission to deliver high-quality, accessible, and compliant biopharmaceutical products while responding to the evolving needs of global healthcare systems.
Global Footprint
CinnaGen has grown into a leading force in healthcare, a progression reflected in our global footprint.
Our products are recognized in many markets and continue progressing through global regulatory pathways. Close collaboration with health authorities ensures quality and safety, while our export network brings CinnaGen therapies to diverse regions and strengthens our role as a trusted global partner.
0+
Over 70 active export destinations
0+
Over 250 marketing authorizations
0
Countries with approvals
0+
Over 200 product registration applications submitted
0
Countries with active applications under review
CinnaGen's Export Locations
Map of locations where CinnaGen products are exported till now
Therapeutic Areas
Driven by a commitment to address complex health challenges and improve patient outcomes, we advance impactful solutions across our therapeutic areas.
Our portfolio spans conditions that significantly affect quality of life, with therapies designed to improve outcomes, enhance access, and support patients through every stage of their treatment journey.
Neurology and Ophthalmology
Oncology and Hematology
Endocrinology and Infertility
Autoimmune and Immunology
Rare Metabolic and Genetic Diseases
Infectious Diseases
Partnership Models
Our drive for meaningful collaboration and sustainable impact is embodied in our partnership models.
Our Partnership models include:
- In-Licensing
- Out-Licensing
- Technology Transfer
- R&D Partnering
- Supply
- Distribution Agreements
- Joint Ventures
- Agency Collaborations
- Contract Manufacturing
each designed to create value, expand access, and foster long-term strategic growth.
But why partner with us?
3 Decades of Expertise
For over 30 years, CinnaGen has grown into a fully integrated biopharma group.
Scaled Manufacturing Capability
An integrated manufacturing ecosystem for delivering reliable, scalable supply
EU-GMP Quality
Our manufacturing meets strict international standards.
Global Reach
CinnaGen therapies serve patients across diverse regions.
Contact Business Development
Our Biosimilar Brochure
bd@cinnagen.com
We are more than a company
We redefine what is possible in the world of medicine.
